Skip to content

Effect of laparoscopic new W-H versus classical Nissen-Rossetti fundoplication for proton pump inhibitor dependent gastroesophageal reflux disease: a multicenter randomized controlled trial

Effect of laparoscopic new W-H versus classical Nissen-Rossetti fundoplication for proton pump inhibitor dependent gastroesophageal reflux disease: a multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081762
Enrollment
Unknown
Registered
2024-03-11
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease

Interventions

Nissen-Rossetti Group:Laparoscopic Hiatal Hernia Repair + Nissen-Rossetti Fundoplication
W-H Group:Laparoscopic Hiatal Hernia Repair + W-H Fundoplication

Sponsors

PLA Rocket Force Characteristic Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Eligible patients must be aged between (include) 18 and 80 years and meet the following criteria: ? Have typical GERD symptoms such as significant regurgitation (regurgitation of acid and/or food), heartburn, and belching (with or without cough, asthma, and pharyngitis et.al.) for more than 6 months, and PPI dependent for more than 3 months cumulatively; ? Require long-term PPI maintenance therapy or are unsatisfied with the therapeutic effects; ? Have undergone upper gastrointestinal endoscopy in the past 6 months that reveals definite esophagitis with or without hiatal hernia, or have a pathological acid exposure as indicated by a 24-hour pH-impedance monitoring with a DeMeester score of = 14.72 or an percentage of acid exposure time of = 4.5%; ? Have undergo esophageal high-resolution manometry to rule out achalasia, nutcracker esophagus, and esophageal outlet obstruction; ? Agree to participate in the randomized controlled trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? A past history of surgery in the esophagus, stomach; ? Patients with coagulation dysfunction, severe cardiopulmonary dysfunction; ? Participated in other clinical studies within the past 3 months; ? Other conditions deemed unsuitable for participation in this clinical research which is assessed by the researchers.

Design outcomes

Primary

MeasureTime frame
the rate of dysphagia at 1 year after the operation;

Secondary

MeasureTime frame
perioperative complication rates;symptom score at 1 year after the operation;subjective relief of symptom at 1 year after the operation;surgical satisfaction rate at 1 year after the operation;off-PPI rate at 1 year after the operation;symptom score for dysphagia at 1 year after the operation;upper gastrointestinal radiography at 1 year after the operation;

Countries

China

Contacts

Public ContactZhiwei Hu

PLA Rocket Force Characteristic Medical Center

higherife@163.com+86 189 1179 3447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026